Clinical review 51: Management of hypercalcemia - PubMed (original) (raw)
Review
Clinical review 51: Management of hypercalcemia
J P Bilezikian. J Clin Endocrinol Metab. 1993 Dec.
Abstract
Hypercalcemia is a very common electrolyte abnormality that is most often seen as a mild elevation in the setting of asymptomatic primary hyperparathyroidism. The hypercalcemia is usually less than 11.2 mg/dL and does not call for specific or vigorous approaches to management. However, more marked elevations in the serum calcium are also seen and call for a more specific approach to management. When the serum calcium is only moderately elevated, the therapeutic approach should be tempered by clinical assessments about the presence of symptoms and the underlying etiology. When the serum calcium is markedly elevated, a more targeted therapeutic approach is called for which now is independent of the presence of symptoms and usually of the underlying etiology. Considerations of hypercalcemia in these three different ranges will tailor the therapeutic approach to the clinical setting.
Similar articles
- Disodium pamidronate in the preoperative treatment of hypercalcemia in patients with primary hyperparathyroidism.
Jansson S, Tisell LE, Lindstedt G, Lundberg PA. Jansson S, et al. Surgery. 1991 Sep;110(3):480-6. Surgery. 1991. PMID: 1845370 - Circulating parathyroid hormone activity: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism.
Marx SJ, Spiegel AM, Brown EM, Windeck R, Gardner DG, Downs RW Jr, Attie M, Aurbach GD. Marx SJ, et al. J Clin Endocrinol Metab. 1978 Dec;47(6):1190-7. doi: 10.1210/jcem-47-6-1190. J Clin Endocrinol Metab. 1978. PMID: 233692 - The medical management of primary hyperparathyroidism.
Bilezikian JP. Bilezikian JP. Ann Intern Med. 1982 Feb;96(2):198-202. doi: 10.7326/0003-4819-96-2-198. Ann Intern Med. 1982. PMID: 7036814 Review. - [Hypercalcemia].
Matikainen N. Matikainen N. Duodecim. 2014;130(14):1404-12. Duodecim. 2014. PMID: 25158579 Review. Finnish. - [Hypercalcemic crisis. Exacerbation of an existing hypercalcemia syndrome].
Hehrmann R. Hehrmann R. Fortschr Med. 1996 Apr 10;114(10):118-22. Fortschr Med. 1996. PMID: 8655116 Review. German.
Cited by
- Risk analysis of fluctuating hypercalcemia after leukapheresis in cellular therapy.
Jo T, Arai Y, Kitawaki T, Nishikori M, Mizumoto C, Kanda J, Yamashita K, Nagao M, Takaori-Kondo A. Jo T, et al. Sci Rep. 2023 Sep 11;13(1):14952. doi: 10.1038/s41598-023-42159-1. Sci Rep. 2023. PMID: 37696885 Free PMC article. - Cancer-related hypercalcemia and potential treatments.
Almuradova E, Cicin I. Almuradova E, et al. Front Endocrinol (Lausanne). 2023 Mar 22;14:1039490. doi: 10.3389/fendo.2023.1039490. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37033238 Free PMC article. Review. - Hypercalcemia in Patients with Williams-Beuren Syndrome.
Sindhar S, Lugo M, Levin MD, Danback JR, Brink BD, Yu E, Dietzen DJ, Clark AL, Purgert CA, Waxler JL, Elder RW, Pober BR, Kozel BA. Sindhar S, et al. J Pediatr. 2016 Nov;178:254-260.e4. doi: 10.1016/j.jpeds.2016.08.027. Epub 2016 Aug 26. J Pediatr. 2016. PMID: 27574996 Free PMC article. - Denosumab for treatment of immobilization-related hypercalcaemia in a patient with advanced renal failure.
de Beus E, Boer WH. de Beus E, et al. Clin Kidney J. 2012 Dec;5(6):566-71. doi: 10.1093/ckj/sfs116. Epub 2012 Oct 7. Clin Kidney J. 2012. PMID: 26069803 Free PMC article. - Acute kidney injury associated with hypercalcaemic crisis in a patient with primary hyperparathyroidism.
Sethi J, Kumar V, Rathi M, Gupta KL. Sethi J, et al. BMJ Case Rep. 2018 Jul 30;2018:bcr2018225235. doi: 10.1136/bcr-2018-225235. BMJ Case Rep. 2018. PMID: 30065055 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous